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Abstract
Autism Spectrum Disorders (ASD) are the second most common developmental cause of disability in the United
States. ASDs are accompanied with substantial economic and emotional cost. The brains of ASD patients have
marked structural abnormalities, in the form of increased dendritic spines and decreased long distance connections.
These structural differences may be due to deficiencies in Heparin Sulfate (HS), a proteoglycan involved in a variety
of neurodevelopmental processes. Of particular interest is its role in the Slit/Robo pathway. The Slit/Robo pathway
is known to be involved in the regulation of axonal guidance and dendritic spine formation. HS mediates the
Slit/Robo interaction; without its presence Slit’s repulsive activity is abrogated. Slit/Robo regulates dendritic spine
formation through its interaction with srGAPs (slit-robo GTPase Activating Proteins), which leads to downstream
signaling, actin cytoskeleton depolymerization and dendritic spine collapse. Through interference with this pathway,
HS deficiency can lead to excess spine formation.
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Background
Autism Spectrum Disorders (ASD) are a set of neuro-
cognitive developmental disorders that are associated
with substantial deficits in social interaction. It is the
second most common developmental disability in the
United States, with approximately 16 out of 10000
people amongst the general population and 14.7 out of
1000 amongst children under eight having an autism
spectrum disorder [1–3]. Amongst children under eight
have autism there is a higher prevalence of autism
amongst boys than girls (one in 42 boys, one in 189
girls) [3]. The associated cost of autism in the United
States is approximately $2.4 million [4]. With the stark
increase in the prevalence of ASD (269 % from 1996 to
2010) and the associated cost of treatment, there has
been an increased interest in the study of ASD
pathophysiology [5]. Amongst the many potential
causes of ASD, deficiencies in Heparan Sulfate (HS)
have garnered interest.
Autism
Along with the social deficits displayed in ASD, substan-
tial structural changes are observed in the autistic brain.
Autistic infants have normal brain size at birth, but
following birth their brains grow faster than normal [6].
After the first critical period in postnatal brain develop-
ment, the brains of autistic patients were 10 % larger [6].
Conversely, during the second and third period of
growth, at ages 2–5 and 5–11, respectively, the brains of
autistic patients experienced delayed growth. Along with
these macrostructural differences, there are also micro-
structural differences in ASD brains. These differences
include disturbances in axons and dendrites as well as in
the number of neurons present. The cerebrum of ASD
patients had excess cortical neurons when compared to
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the non-ASD brain. In contrast, the cerebellum displayed
a lower number of neurons, in particular Purkinje cells.
The white matter of the cerebrum also exhibited abnor-
malities, such as thin axons and less myelinated axons
than controls [7]. Both of these morphological changes
are associated with increased short distance connections,
accompanied by decreased long distance connections.
The white matter of ASD patients displayed high
levels of GAP-43 (growth associated protein-43), a
substance associated with cell proliferation, suggesting
excess neurogenesis. This supports past findings of
excess neurons in the cerebrum of patients with ASD.
Various abnormalities in dendrite morphology are
observed in the autistic brain. For a normal child the
frontal cortex does not reach its full level of dendritic
arborization until the end of childhood, with 3 % of its
size present at birth and only 48 % present at 2 years [6].
The cerebral cortex develops more slowly than other
brain areas [6]. The extended time it takes for the frontal
cortex to develop makes it especially vulnerable to dis-
ruption. One study on postmortem brain tissue showed
significant differences between the dendritic spines of
ASD brains and controls [8]. ASD brains had a higher
average density with the difference most apparent in the
second layer. Layer V also had a significant relationship
with diagnosis, with ASD brains having higher densities
in the temporal lobe. In addition to the increase in spine
density, shorter spines were also observed in ASD
brains. There was also notable differences in the type of
dendritic spines present. There were more oblique
spines in ASD patients than in controls. The oblique
spines also had a greater spine density than either apical
or basilar spines did within ASD brains, in controls the
spine densities were more similar across type. The dens-
ity of apical spines within Layer II was found to be
higher in ASD subjects than in controls [8].
Exposure to valproic acid, an anticonvulsant in utero
has been linked to autism and other cognitive deficits
[9, 10]. A study on rat embryos exposed to valproic
acid has led to insight into the structure of ASD
brains. Pregnant rats were exposed to valproic acid at
gestational day 11.5 [9]. The rats were sacrificed
2 weeks after birth and the microcircuitry of the rats
was examined. Synapses showed reduced maximum
activity and a weaker excitatory synapse response. The
experimental group had an average maximum synaptic
output of 3.3 ± 0.3 mV compared with an average of
4.2 ± 0.4 mV for control synapses. Greater current was
needed to produce an action potential for Layer V
neurons 400 ± 16 pA, n = 51 were needed for the
control group, and 444 ± 16 pA, n = 31 for the expe-
rimental group. There was also a possible increase in
local wiring. The number of direct connections
increased 50 % at short distances (~50 μm), while
there was no difference for long distance connections
(100–200 μm) [9]. There was also an increased prob-
ability of interneuron connections. Accompanying this
increase there was hyperactivity at the local level with
an increase in the synaptic release of excitatory neuro-
transmitters. In all there appeared to be more connec-
tions and neurotransmitter release, but weaker signals
and communication.
Together, these findings suggest that the ASD brain
never progresses past the early part of brain development,
which is characterized by excess neurogenesis and imma-
ture synaptic connections. While the structural changes in
the ASD brain have been characterized, it is unclear what
causes these changes. There is some suggestion that
Heparan Sulfate deficiencies may play a role.
Heparan sulfate
Heparin Sulfate (HS) is a proteoglycan that has a variety
of biological roles. Proteoglycans are made of chains of
highly charged glycosaminoglycans (GAGs). There are
five classes of HS which include: membrane syndecans,
glycosyl-phosphatidylinositol-anchored (GPI-anchored)
glypicans, perlecan, agrin, and hybrid HSPG/collagen
type XVIII [11]. Most of the cell-surface HS is in the
form of syndecans, which are integral membrane pro-
teins [12]. There are six glypicans in vertebrates, and
glypicans may play a role in growth factor signaling
pathways [11, 12]. Perlecan and agrin are two of the
three proteoglycans of the basement membrane [13].
Perlecan is important in cell differentiation and embryo-
genesis [13]. Agrin is the main proteoglycan at the
neuromuscular junction and causes the aggregation of
acetylcholine receptors [13].
HS is formed in a multiple step process which
includes: the formation of a membrane bound protein
core (in the case of membrane bound HS), initiation/
elongation of the GAG, and various sulfation or de-
acetylation steps. HS synthesis is a highly evolutionarily
conserved synthesis pathway consisting of 14 steps [11, 12].
The process requires several enzymes making it vulnerable
to mutations, being that a mutation of one enzyme could
prevent subsequent steps. The first step, mediated by
peptide-O-xylosyltransferase, initiates the GAG chain on
the protein core [14]. The GAG chain constituents
themselves are formed in the Golgi apparatus by various
enzymes [15]. HS GAG chains consist of repeats of 2
N-Acetylglucosamine (GlcNAc) units and 1 Glucuronic
acid (GlcA) unit [15]. The 2 GlcNAc units are added to
the chain by galactosyltransferases-I and –II and the
GlcA is added by Glucuronyltransferase I [15]. GlcA is
donated by UDP-glucuronic acid which is produced by
UDP glucose dehydrogenase (UDPGDH) [12]. Contin-
ued elongation of the GAG chain is accomplished by
exostosin (EXT)-family co-polymerases (EXT1, EXT2,
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EXTL1, EXTL2 and EXTL3), a family of proteins with
highly conversed C-terminals, which are thought to be
involved in HS synthesis [14–16]. A heteroligomeric
complex of EXT1 and EXT2 polymerizes the GAG
chain in HS, the roles of EXTL1, EXTL2, EXTL3 are
still unknown, although sequence homology suggest
that there function is similar to that of EXT1 and EXT2
[14–16]. Once elongation is completed HS chains are
typically ∼ 5 to ∼ 70 kDa in GAGs attached to the
protein core [11]. Following the formation of the GAG
chain, the proteoglycan undergoes several modifications
including: C5 epimerization of GlcA, de-acetylation and
multiple sulfation [14, 15]. The C5 epimerization of
GlcA is mediated by heparan sulfate C5 epimerase (HS
C5-EP) [15]. The multiple sulfation steps lead to many
different patterns, which are regulated in a cell specific
way [15]. The sulfation patterns of HS modify cellular
activity and signaling in different ways, such as providing
different axonal guidance cues [14]. The multiple sulfation
steps are mediated by several different enzymes: HS 2-O-
sulfotransferases (H2ST) which transfers sulfate to GlcA/
IdoA residues, 6-O-sulfotransferases (H6ST-1, −2, −2S
and −3) which catalyzes GlcN 6-O-sulfation, and 3-O-
sulfotransferases (H3ST-1, −2, −3A, −3B, −4, −5 and −6)
which catalyzes GlcN 3-O-sulfation [12, 15].
The biological roles of HS have been known to include
the mass migration of cells, the protection of FGF from
proteolysis, and the formation of the extracellular matrix
(ECM) [12, 17]. It is well known that HS has a role in
neural development, through the modulation of neuro-
genesis, axonal guidance, and synaptogenesis [18]. HS
has regulated neural connectivity since cnidarians and it
is thought to have appeared around the time that the
first nervous systems did [14, 19]. This suggests that HS
is necessary for proper neural development. Its role in
the protection of FGF-2 is critical to neurogenesis, since
FGF-2 is a critical growth factor in neural stem cell (NSCs)
differentiation and proliferation [18]. Also glypican-4
(K-glypican) is highly expressed in the developing
brain of embryos [20]. Furthermore, glypican-4 is
expressed primarily in the ventricular zone of the
telencephalon, suggesting that it plays a role in cere-
bral neurogenesis [21]. Glypican-4 was found to be
expressed with nestin, a marker for neural progenitor
cells, further suggesting its role in neurogenesis [21].
Perlecan also interacts with FGF-2 by acting as its co-
receptor [18]. Syndecan-3 has been found on growth
cone surfaces and implicated in axonal guidance [18].
Syndecan-3 also interacts with the post synaptic
protein CASK, possibly contributing to synapse for-
mation [15, 18]. HS also plays a role in the activity of
neurotropic factors, ECM, cell adhesion molecules
(CAMs), morphogens, and chemotropic factors [14].
HS has also been shown to facilitate axonal growth,
but the associated increase of HS at the sight of injury
has been shown to inhibit axonal regrowth [14]. HS is
necessary for Slit, Ephrin-A3, and Semaphorin 5A
axonal guidance signal pathways [14, 15]. It is thought
that the sulfation of HS creates a code that modifies
the activity of these signaling pathways [14]. Furthermore,
Syndecan-2, another type of HS, has been linked to
dendritic spine maturation [22]. HS’s role in neurodeve-
lopmental processes has made it of interest in the study of
neurodevelopmental disorders, in particular autism.
HS deficiencies have been linked to autism [23]. In
one study, conditional EXT knockout (KO) mice were
shown to have many of the stereotyped behaviors associ-
ated with autism [23]. The conditional KO did not have
EXT in neurons, an enzyme vital in the polymerization
of HS, making the conditional KO mice HS deficient
[23, 24]. The HS deficiency was at its greatest in the
amygdala and hippocampus, regions important to mem-
ory and leaning [23]. The brains of the mice showed no
structural, tract abnormalities or myelination abnormal-
ities observed in ASD brains [7, 23]. There was also no
difference in dendritic spines as is typical with ASD
[7, 23]. This can be explained by the late onset nature
of the conditional knockout [23].
There were no observed motor function deficits, but
there were significant social deficits observed [23]. EXT
KO mice displayed reduced nest building, a stereotyped
behavior associated with autism. The mice also showed
behavior associated with autism during the Separation-
reunion test, Resident-intruder test, Social dominance
tube test, and Holed-board test. The KO mice had ultra-
sonic vocalizations (USV) that were reduced in number,
amplitude, and duration. The mice also had hypersensi-
tivity to a hot plate. Mapping of neuronal activity was
conducted with Neuronal c-Fos induction as an activity
marker. Activity was found to be lower in the basolateral
and medial amygdala as well as the ventral orbitofrontal
cortex of KO mice when compared to controls. Similar
to other autism studies, the KO mice brains showed
inhibited synaptic response to excitatory stimuli [9, 23].
This decrease in response could be due to the associated
decreased level of AMPA [23]. Furthermore, two brothers
with mental retardation associated autism, were shown to
have EXT mutations [25]. Suggesting disruptions in EXT
mediated GAG chain elongation can play a role in ASD
pathogenesis. In addition, these studies suggest the
social behavioral abnormalities associated with HS de-
ficiency can begin long before morphological changes
are noticeable.
The BTBR mouse model of autism has shown a reduc-
tion in HS associated in fractones in the subventricular
zone (SVZ) [26]. The number of fractones in the control
brain was an average of 1080 for two brains, while the
BTBR mice had an average 345 for two brains. Along
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with the reduction in HS fractones there were noticeable
structural differences. Agenesis of corpus callosum was
observed as well as reduced size of latent ventricular
cavities. There was a 40 % decrease in the length of the
SVZ measured in the midline of the HS-ir, suggestive of
a decrease in neurogenesis.
In the brains of autistic individuals HS was deficient in
the Hypocellular Layer (II) region of the SVZ of the
lateral ventricle (LV-SVZ) [27]. It is worth noting that
this deficiency disappeared with age. This lack of HS
deficiency in older ASD brains may be explained by the
natural decrease in HS in the aging brain. The brains of
5–6 years old ASD patients showed an increase in cell
proliferation. This seems to contradict research on BRBR
mice suggesting decreased neurogenesis, but is consist-
ent with other postmortem studies on human brain
tissue which suggest that early in development the ASD
brain undergoes excess neurogenesis [6, 26, 27]. The
increased neurogenesis was colocalized with the HS
deficiency, suggesting HS can decrease neurogenesis
[27]. The discrepancy between studies could have to do
with the differences in HS levels. The colocalization of
GFAP with neurogenesis is consistent with the presence
of Type I progenitors. The cell proliferation was local-
ized with the HS deficiency, implying that HS inhibits
neurogenesis. The increased neurogenesis dissipated
with age, which is curious being that HS deficiency also
dissipated with age.
It has also been shown that ASD patients have a
sulfate metabolism impairment as evident by reduced
levels of sulfates in the plasma of ASD [19]. One study
on 38 ASD participants and greater than 25 age matched
(ages 2–16) controls, showed that along with reduced
levels of plasma sulfate ASD patients also showed
reduced transulfation metabolites such as: taurine, gluta-
thione and cysteine [28]. The average total plasma
sulfate of ASD patients is 934 ± 252 μmol/l versus an
average of 1,930 ± 184 μmol/l for controls [28]. ASD
patients were also shown to have increased plasma
oxidative glutathione, which is indicative of cell damage
[28]. In addition to having low plasma sulfate levels,
sulfate was excreted at a higher level in ASD individuals:
6819.0 nmol/ml and 3030.8 nmol/ml in controls [29].
This is of particular interest because peptidoglycan sulfa-
tion patterns affect HS activity and function [19, 30].
One type of HS sulfotranferase, Phenol Sulfotransferase,
has been linked to autism [31]. An autism genetic study
found an abnormality on chromosome 16p12.1-11.2, the
location of the Phenol Sulfotransferase gene [31]. Fluor-
escence in situ hybridization (FISH) detected a microde-
letion of 16p11.2 that was not present in any of the
controls [32]. A second study found that deletion or
duplication of 16p11.2 is found in 1 % of those with
autism and 1.5 % of those with developmental delays
[33]. Along with excess sulfate excretion in patients with
ASD there is also evidence of a threefold or greater
increase of GAG excretion in ASD patients [34]. This
points to HS defiency as a potential cause of autism.
It is unclear how a deficiency in HS can lead to autism,
but it is known that HS has a role in the early develop-
ment of the nervous system. HS is involved in synapto-
genesis, axonal guidance, neural migration, and dendritic
spine formation in the developing brain [14, 18, 35]. It
appears that axonal guidance disruptions and dendritic
spine deformation are the most likely candidates, because
both have been shown in autism cases [36, 37]. This along
with the HS deficiencies in rat models of autism makes
the role of HS in the regulation of these processes a good
target for autism research.
Slit/Robo
One way in which HS regulates these processes is through
its interaction with the Slit/Robo signaling pathway.
Slit/Robo regulates thalamocortical projections, forebrain
commissure formation, axonal guidance, and dendritic
spine formation [38–40]. Robo is a cell-surface receptor
and Slit is one of its ligands. Robo is a CAM in the
immunoglobulin super family [41]. There are four mem-
bers of the Robo family present in mammals, all of which
have five immunoglobulin-like (IG) domains and three
fibronectin-like repeats [42–44]. IG1 and IG2 of the five
IG domains have been shown to be necessary for Slit/
Robo interaction [42]. Slit is known for its four leucine-
rich repeat (LRR) domains located in the N-terminus,
which are labeled D1-D4 [42]. Studies on Slit have shown
that Slit can function without the C-terminus in vitro;
hence, the LRR domain is necessary for Slit/Robo signal-
ing while the C-terminus is not, but this has yet to be
tested in vivo [42]. The Slit/Robo interaction is a high
affinity interaction [42]. Much work has gone into under-
standing this interaction. Through work with xenopus it
was found that the highly conserved D2 domain is the
binding site for Robo [42]. It appears that the D2 domain
of Slit binds with the IG1 domain of Robo [42]. The
residues that mediate this interaction are Thr-74, Phe-114,
and Arg-117 of IG1 [45]. While the IG2 domain of Robo
is not the binding site of Slit, it appears to be necessary for
the proper folding of the IG1 domain [42].
HS has been shown to affect Slit’s affinity to Robo
[41, 46]. In one study, HS was removed from the cell
surface of Robo1 expressing cells and Slit2 binding
was reduced by threefold [46]. It was also found that
the repulsive effects of Slit2 on the cellular projections
was abolished in vitro when cell surface HS was
removed by heparinase III [46]. Slit’s interaction with
HS is mediated by the D4 domain of Slit [47]. The D4
domain has five LRRs with one cysteine-rich domain
on each end [47]. These domains together form a
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seven stranded β-sheet [47]. The interaction between
D4 and HS is mediated by three highly positive basic
patches at the bottom of the D4 [47]. Specifically, it
has been shown that sulphate forms hydrogen bonds
with the Tyr 810 and His 833 residues [47]. This is a
highly conserved pattern across Slit domains [47]. The
D4 domain is also involved in the dimerization of Slit
[47]. It is believed that the Slit dimer, Robo, and cell-
surface HS form a tetrameric complex [47].
HS’s pivotal involvement in the Slit/Robo interaction,
and furthermore, Slit/Robo involvement in axonal guid-
ance and dendritic spine formation, make this signaling
pathway of interest when exploring the pathogenesis of
autism. Robo1 and Robo2 has also been shown to be
deficient in some cases of autism, suggesting that this
pathway may be a possible mechanism by which HS
deficiency could cause autism [37, 48]. Furthermore, in
one study the Robo2 deficiency was associated with the
anterior cingulate cortex, an area of the brain associated
with social cognition [37]. Slit expression was found to
be increased in ASD group in comparison to the control
group [40]. In addition, a role for Slit/Robo malfunction-
ing in autism, dyslexia and other speech disorders is
supported by a recent study showing that vocal learning
birds (songbird, parrot and hummingbird) make a rela-
tively rare connection between vocal learning circuits of
the forebrain and brainstem vocal motor neurons, not
seen in vocal nonlearning bird species or mice, mediated
by specialized regulation of SLIT-ROBO genes [49]. The
role of Slit/Robo in autism is clearly an important area
for further study.
If Slit/Robo signaling leads to autism, does it do so
through its role in axonal guidance or through its role in
dendritic spine formation? Both changes in long-distance
connections and dendritic spine morphology are present,
so presumably either is possible. It seems that a connec-
tion to dendritic spines is more plausible, when you
consider that several autism related disorders have been
linked to dendritic spine dysgenesis [36]. Syndycan-2 also
is expressed in high levels in dendritic spines and has been
linked to spine maturation [22]. A female with mental
retardation, multiple exostoses, and autism was shown to
have an X;8 translocation, involved in the GRPR gene, and
the SDC2 gene which codes Syndecan-2 [50]. This suggest
that Syndecan-2 and dendritic spine dysgenesis are related
to autism. Furthermore, it has been shown that Slit1
treated neurons had morphological changes in dendritic
spines [39]. This suggest Slit plays a key role in dendritic
spine formation.
srGAPs
Slit/Robo regulates the formation of dendritic spines
through an interaction with srGAPs (slit-robo GTPase
Activating Proteins) [38, 51]. srGAPs are a family of
small guanine triphosphatase activating proteins, which
act on the Rho GTPase family [52]. Rho GTPase family
members include Rac, Cdc42 and Rho, all of which are
members of the RAS superfamily [53–55]. srGAPs are
regulators of the actin cytoskeleton, which has been
shown to be involved in the formation of growth cones
of the neural cytoskeleton [38, 53, 55, 56]. There are
three forms of srGAPs identified in humans: srGAP1,
srGAP2 and srGAP3 [52]. srGAP1 lessens the formation
of cellular protrusions, while srGAP2 and srGAP3 in-
crease the formation of cellular protrusions [38, 57]. All
the srGAPs are highly expressed in the brain, especially
in the forebrain [52, 58]. All three srGAPs are mainly
located in the neurons, but not the glia [58]. Robo1,
srGAP1 and srGAP2 were found in the anterior SVZ,
suggesting that the Robo1/srGAP interaction plays a role
in either neurogenesis or the migration of newly formed
neurons [52]. Of greater interest is the localization of
srGAP1 in the nuclei of neurons in the cerebral cortex
layers II–VI [58]. Abnormal increases in the densities of
dendritic spines in ASD patients have been noted for
these layers. In light of the role of srGAP1 in lessening
cellular protrusions, autism may be linked to distur-
bances in this pathway. To answer this question, the
processes of how srGAPs mediates dendritic spine
ormation must be explored.
srGAPs has been found to be collocated with synapses
and the heads of dendritic spines [59]. Immature spines
are observed when srGAPs is inhibited [59]. Also KO
mice had immature and more numerous spines [59].
srGAPs has been shown to interact with Robo during
the process of dendritic spine formation [38, 59]. srGAP
and Robo receptors have been found to be collocated in
rat brain samples, suggesting that the srGAP/Robo
relationship may mediate the dendritic spine formation
[58]. Robo has also been shown to have an effect on
dendritic spine formation [39].
Slit regulates this interaction between srGAPs and
Robo [51]. To understand the srGAPs/Robo interaction
we must first understand the structure of srGAPs.
srGAPs consist of a RhoGAP domain, a SH3 domain,
and a Fes/CIP4 homology (FCH) domain [52]. The Slit/
Robo interaction is mediated by the SH3 domain of
srGAPs and the proline-rich CC3 motif of Robo1 [52].
The SH3 site of srGAPs is contained in several different
proteins and is involved in many signaling pathways
[60]. The SH3 region has a hydrophobic cleft that acts
as a recognition site. This hydrophobic cleft recognizes
proteins that have a PXXP motif, in which X is usually
arginine or a hydrophobic residue. This PXXP motif
forms what is known as a collagen chain conformation.
The hydrophobic cleft of SH3 interacts with Robo. Robo
has four motifs: CC0, CC1, CC2, and CC3. CC3 is a
proline rich motif that mediates Robo’s interaction with
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the PXXP recognition site of srGAPs. CC3 has a highly
conserved sequence of TYTDDLPPPPVPPPAIKSP [PIR:
Q1RMC8], which interacts with the hydrophobic cleft
of SH3.
It is believed that Slit binds to Robo1 enhancing the
ability of srGAP1 to bind to Robo1 [51]. This activates
srGAP1 which inactivates Cdc42 (a Rho GTPase),
which phosphates N-WASP and activates it [51].
Inactivating Cdc42, therefore decreases the activation
of N-WASP, which decreases activation of Arp2/3
[51]. Arp2/3 promotes actin polymerization and its
deactivation causes dendritic spine collapse [51]. In
this way Slits repulsive effects may cause the collapse
of dendritic spines. The malfunctioning of this path-
way may increase dendritic spine formation, mediated
by the increased activity of Arp2/3.
Alternative mechanism
As noted earlier a disruption of Slit/Robo signaling
could also lead to autism, by affecting axonal guid-
ance. Disturbances of axonal guidance have been
shown in valproic acid treated mice and postmortem
ASD studies, suggesting that disruptions in axonal
guidance may contribute to the etiology of autism [7, 9].
One problem with this mechanism is that Slit is a repul-
sive guidance cue, which leads to growth cone collapse.
Axons in ASD make fewer long distance connections
[7, 9]. The opposite would be expected if Slit/Robo
signaling was reduced.
Conclusion
Increased dendritic spine formation is a feature of autism
[8]. The relationship between Slit/Robo and srGAPs with
excess spine formation suggests a potential mechanism by
which a HS deficiency can cause autism. The deficiency of
HS could lead to a decrease in the interaction between
Robo1 and Slit, and this in turn will decrease the binding
of Robo1 and srGAP1. Ultimately, this will lead to
an upstream increase in actin polymerization. This
also suggests a mechanism by which decreased Robo1
could lead to autism. The Robo1 deficiency leads to
decreased interaction with srGAP1, leading to up-
stream actin polymerization. Disruptions in this path-
way could also be related to the presence of excess
sAPPα in autistic brains [61]. sAPPα is linked to in-
creased neurite formation and is also known to bind
HS [62, 63]. It is possible that this binding could inter-
fere with Slit/Robo signaling.
While the interaction of srGAPs with Slit/Robo has
been investigated, it has not been investigated in a Robo
deficient environment or HS deficient environment. An
investigation of how these deficiencies affects the inter-
action of srGAPs with Slit/Robo and the downstream
dendritic spine formation could provide insights into
autism. It could be insightful to study the Slit/Robo
activity of EXT KO mice to determine if this pathway is
indeed affected by HS deficiency. Furthermore an inves-
tigation on Robo KO mice might help determine if this
pathway effects dendritic spine morphology.
Abbreviations
ASD: autism spectrum disorders; HS: heparan sulfate; srGAPs: slit/robo
GTPase activating proteins; SVZ: sub-ventricular zone; LV-SVZ: lateral ventricle
sub-ventricular zone; LRR: leucine-rich repeats; IG: immunoglobulin-like;
CAM: cellular adhesion molecule; FCH: Fes/CIP4 homology;
FISH: fluorescence in situ hybridization; NSCs: neural stem cells;
USV: ultrasonic vocalizations; ECM: extra-cellular matrix; GlcA: glucuronic acid;
H2ST: HS 2-O-sulfotransferases; HS C5-EP: heparan sulfate C5 epimerase;
EXT: exostosin; GlcNAc: N-acetylglucosamine; UDPGDH: UDP glucose
dehydrogenase; H6ST: 6-O-sulfotransferases; KO: knockout.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
CP reviewed the literature, wrote and edited this article. DS edited this
article. JT contributed to the initial idea of the review. All authors read and
approved this article.
Authors’ information
CP has an MS in Aging and Neuroscience from the University of South
Florida. DS is an assistant researcher and professor of psychiatry at the
University of South Florida Morsani College of Medicine. JT is the Silver
Endowment Chair and a professor of psychiatry at the Morsani College
of Medicine.
Acknowledgements
This work was supported by the Silver Endowment. JT holds the Sliver Chair
in Developmental Neurobiology.
Received: 4 November 2015 Accepted: 12 April 2016
References
1. Volker MA, Lopata C. Autism: a review of biological bases,
assessment, and intervention. Sch Psychol Q. 2008;23(2):258–70.
doi:10.1037/1045-3830.23.2.258.
2. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, et al. The
epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007;
28:235–58. doi:10.1146/annurev.publhealth.28.021406.144007.
3. Prevalence of autism spectrum disorder among children aged 8 years
- autism and developmental disabilities monitoring network, 11 sites,
United States, 2010. Morb Mortal Wkly Rep Surveill Summ
(Washington, DC : 2002). 2014;63(2):1–21.
4. Barrett B. Substantial lifelong cost of autism spectrum disorder. J Pediatr.
2014;165(5):1068–9. doi:10.1016/j.jpeds.2014.08.016.
5. Van Naarden BK, Christensen D, Doernberg N, Schieve L, Rice C, Wiggins L,
et al. Trends in the prevalence of autism spectrum disorder, cerebral palsy,
hearing loss, intellectual disability, and vision impairment, metropolitan
atlanta, 1991–2010. PLoS One. 2015;10(4):e0124120. doi:10.1371/journal.
pone.0124120.
6. Courchesne E, Redcay E, Morgan JT, Kennedy DP. Autism at the beginning:
microstructural and growth abnormalities underlying the cognitive and
behavioral phenotype of autism. Dev Psychopathol. 2005;17(3):577–97.
doi:10.1017/s0954579405050285.
7. Zikopoulos B, Barbas H. Changes in prefrontal axons may disrupt the
network in autism. J Neurosci. 2010;30(44):14595–609. doi:10.1523/
JNEUROSCI.2257-10.2010.
8. Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical
projection neurons in autism spectrum disorders. Brain Res. 2010;1309:
83–94. doi:10.1016/j.brainres.2009.09.120.
9. Rinaldi T, Silberberg G, Markram H. Hyperconnectivity of local neocortical
microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex
(New York, NY : 1991). 2008;18(4):763–70. doi:10.1093/cercor/bhm117.
Pérez et al. Neural Development  (2016) 11:11 Page 6 of 8
10. Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism–a
current review of clinical and animal studies. Neurotoxicol Teratol. 2013;36:
47–56. doi:10.1016/j.ntt.2013.01.004.
11. Iozzo RV. Heparan sulfate proteoglycans: intricate molecules with intriguing
functions. J Clin Invest. 2001;108(2):165–7. doi:10.1172/jci13560.
12. Lander AD, Selleck SB. The elusive functions of proteoglycans: in vivo
veritas. J Cell Biol. 2000;148(2):227–32.
13. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function.
Annu Rev Biochem. 1998;67:609–52. doi:10.1146/annurev.biochem.67.1.609.
14. Van Vactor D, Wall DP, Johnson KG. Heparan sulfate proteoglycans and the
emergence of neuronal connectivity. Curr Opin Neurobiol. 2006;16(1):40–51.
doi:10.1016/j.conb.2006.01.011.
15. Maeda N, Ishii M, Nishimura K, Kamimura K. Functions of chondroitin sulfate
and heparan sulfate in the developing brain. Neurochem Res. 2011;36(7):
1228–40. doi:10.1007/s11064-010-0324-y.
16. Busse-Wicher M, Wicher KB, Kusche-Gullberg M. The exostosin family:
proteins with many functions. Matrix Biol. 2014;35:25–33. doi:10.1016/j.
matbio.2013.10.001.
17. Venero Galanternik M, Kramer KL, Piotrowski T. Heparan sulfate
proteoglycans regulate Fgf signaling and cell polarity during collective cell
migration. Cell Rep. 2015. doi:10.1016/j.celrep.2014.12.043.
18. Yamaguchi Y. Heparan sulfate proteoglycans in the nervous system: their
diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin
Cell Dev Biol. 2001;12(2):99–106. doi:10.1006/scdb.2000.0238.
19. Hartzell S, Seneff S. Impaired sulfate metabolism and epigenetics: is there a
link in autism? Entropy. 2012;14(10):1953.
20. Watanabe K, Yamada H, Yamaguchi Y. K-glypican: a novel GPI-anchored
heparan sulfate proteoglycan that is highly expressed in developing brain
and kidney. J Cell Biol. 1995;130(5):1207–18.
21. Hagihara K, Watanabe K, Chun J, Yamaguchi Y. Glypican-4 is an
FGF2-binding heparan sulfate proteoglycan expressed in neural
precursor cells. Dev Dyn. 2000;219(3):353–67. doi:10.1002/1097-0177(2000)9999:
9999<::aid-dvdy1059>3.0.co;2-#.
22. Ethell IM, Yamaguchi Y. Cell surface heparan sulfate proteoglycan syndecan-2
induces the maturation of dendritic spines in rat hippocampal neurons. J Cell
Biol. 1999;144(3):575–86.
23. Irie F, Badie-Mahdavi H, Yamaguchi Y. Autism-like socio-communicative
deficits and stereotypies in mice lacking heparan sulfate. Proc Natl Acad
Sci U S A. 2012;109(13):5052–6. doi:10.1073/pnas.1117881109.
24. Yamaguchi Y, Inatani M, Matsumoto Y, Ogawa J, Irie F. Roles of heparan
sulfate in mammalian brain development current views based on the
findings from Ext1 conditional knockout studies. Prog Mol Biol Transl Sci.
2010;93:133–52. doi:10.1016/s1877-1173(10)93007-x.
25. Li H, Yamagata T, Mori M, Momoi MY. Association of autism in two patients
with hereditary multiple exostoses caused by novel deletion mutations of
EXT1. J Hum Genet. 2002;47(5):262–5. doi:10.1007/s100380200036.
26. Meyza KZ, Blanchard DC, Pearson BL, Pobbe RLH, Blanchard RJ.
Fractone-associated N-sulfated heparan sulfate shows reduced quantity
in BTBR T+tf/J mice, a strong model of autism. Behav Brain Res. 2012;
228(2):247–53. doi:10.1016/j.bbr.2011.11.004.
27. Pearson BL, Corley MJ, Vasconcellos A, Blanchard DC, Blanchard RJ.
Heparan sulfate deficiency in autistic postmortem brain tissue from the
subventricular zone of the lateral ventricles. Behav Brain Res. 2013;243:
138–45. doi:10.1016/j.bbr.2012.12.062.
28. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. A prospective
study of transsulfuration biomarkers in autistic disorders. Neurochem Res.
2009;34(2):386–93. doi:10.1007/s11064-008-9782-x.
29. Waring RH, Klovrza LV. Sulphur metabolism in autism. J Nutr Environ Med.
2000;10(1):25–32. doi:10.1080/13590840050000861.
30. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CLR, Dierks T. The
heparanome—the enigma of encoding and decoding heparan sulfate sulfation.
J Biotechnol. 2007;129(2):290–307. http://dx.doi.org/10.1016/j.jbiotec.2007.01.022.
31. Dooley TP, Obermoeller RD, Leiter EH, Chapman HD, Falany CN, Deng Z, et al.
Mapping of the phenol sulfotransferase gene (STP) to human chromosome
16p12. 1-p11. 2 and to mouse chromosome 7. Genomics. 1993;18(2):440–3.
32. Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C, Badner JA, et al.
Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet. 2008;17(4):
628–38. doi:10.1093/hmg/ddm376.
33. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, et al. Association
between microdeletion and microduplication at 16p11.2 and autism. N Engl
J Med. 2008;358(7):667–75. doi:10.1056/NEJMoa075974.
34. Endreffy I, Bjorklund G, Dicso F, Urbina MA, Endreffy E. Acid
glycosaminoglycan (aGAG) excretion is increased in children with
autism spectrum disorder, and it can be controlled by diet. Metab
Brain Dis. 2015. doi:10.1007/s11011-015-9745-2.
35. Lee JS, Chien CB. When sugars guide axons: insights from heparan sulphate
proteoglycan mutants. Nat Rev Genet. 2004;5(12):923–35. doi:10.1038/nrg1490.
36. Phillips M, Pozzo-Miller L. Dendritic spine dysgenesis in autism related
disorders. Neurosci Lett. 2015. doi:10.1016/j.neulet.2015.01.011.
37. Suda S, Iwata K, Shimmura C, Kameno Y, Anitha A, Thanseem I, et al.
Decreased expression of axon-guidance receptors in the anterior cingulate
cortex in autism. Mol Autism. 2011;2(1):14. doi:10.1186/2040-2392-2-14.
38. Blockus H, Chédotal A. The multifaceted roles of Slits and Robos in cortical
circuits: from proliferation to axon guidance and neurological diseases. Curr
Opin Neurobiol. 2014;27(0):82–8. http://dx.doi.org/10.1016/j.conb.2014.03.003.
39. Whitford KL, Marillat V, Stein E, Goodman CS, Tessier-Lavigne M, Chedotal A,
et al. Regulation of cortical dendrite development by Slit-Robo interactions.
Neuron. 2002;33(1):47–61.
40. Bakos J, Bacova Z, Grant SG, Castejon AM, Ostatnikova D. Are molecules
involved in neuritogenesis and axon guidance related to autism pathogenesis?
Neruomol Med. 2015;17(3):297–304. doi:10.1007/s12017-015-8357-7.
41. Ypsilanti AR, Zagar Y, Chedotal A. Moving away from the midline: new
developments for Slit and Robo. Development (Cambridge, England). 2010;
137(12):1939–52. doi:10.1242/dev.044511.
42. Hohenester E. Structural insight into Slit-Robo signalling. Biochem Soc Trans.
2008;36(Pt 2):251–6. doi:10.1042/bst0360251.
43. Jones CA, London NR, Chen H, Park KW, Sauvaget D, Stockton RA, et al.
Robo4 stabilizes the vascular network by inhibiting pathologic
angiogenesis and endothelial hyperpermeability. Nat Med. 2008;14(4):
448–53. doi:10.1038/nm1742.
44. Bedell VM, Yeo SY, Park KW, Chung J, Seth P, Shivalingappa V, et al.
roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A.
2005;102(18):6373–8. doi:10.1073/pnas.0408318102.
45. Fukuhara N, Howitt JA, Hussain SA, Hohenester E. Structural and
functional analysis of slit and heparin binding to immunoglobulin-like
domains 1 and 2 of Drosophila Robo. J Biol Chem. 2008;283(23):
16226–34. doi:10.1074/jbc.M800688200.
46. Hu H. Cell-surface heparan sulfate is involved in the repulsive guidance
activities of Slit2 protein. Nat Neurosci. 2001;4(7):695–701. doi:10.1038/89482.
47. Seiradake E, von Philipsborn AC, Henry M, Fritz M, Lortat-Jacob H, Jamin M,
et al. Structure and functional relevance of the Slit2 homodimerization
domain. EMBO Rep. 2009;10(7):736–41. doi:10.1038/embor.2009.95.
48. Anitha A, Nakamura K, Yamada K, Suda S, Thanseem I, Tsujii M, et al. Genetic
analyses of Roundabout (ROBO) axon guidance receptors in autism. Am
J Med Genet B Neuropsychiatr Genet. 2008;147B(7):1019–27. doi:10.1002/
ajmg.b.30697.
49. Wang R, Chen CC, Hara E, Rivas MV, Roulhac PL, Howard JT, et al.
Convergent differential regulation of SLIT-ROBO axon guidance genes in
the brains of vocal learners. J Comp Neurol. 2015;523(6):892–906.
doi:10.1002/cne.23719.
50. Ishikawa-Brush Y, Powell JF, Bolton P, Miller AP, Francis F, Willard HF, et al.
Autism and multiple exostoses associated with an X;8 translocation
occurring within the GRPR gene and 3′ to the SDC2 gene. Hum Mol Genet.
1997;6(8):1241–50.
51. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, et al. Signal transduction
in neuronal migration: roles of GTPase activating proteins and the small
GTPase Cdc42 in the Slit-Robo pathway. Cell. 2001;107(2):209–21.
52. Ghose A, Van Vactor D. GAPs in Slit-Robo signaling. BioEssays. 2002;24(5):
401–4. doi:10.1002/bies.10080.
53. Dickson BJ. Rho GTPases in growth cone guidance. Curr Opin Neurobiol.
2001;11(1):103–10.
54. Hall A, Nobes CD. Rho GTPases: molecular switches that control the
organization and dynamics of the actin cytoskeleton. Philos Trans R Soc
Lond B Biol Sci. 2000;355(1399):965–70. doi:10.1098/rstb.2000.0632.
55. Hall A. Rho GTPases and the actin cytoskeleton. Science (New York, NY).
1998;279(5350):509–14.
56. Luo L, Jan LY, Jan Y-N. Rho family small GTP-binding proteins in growth
cone signalling. Curr Opin Neurobiol. 1997;7(1):81–6. http://dx.doi.org/10.
1016/S0959-4388(97)80124-9.
57. Coutinho-Budd J, Ghukasyan V, Zylka MJ, Polleux F. The F-BAR domains
from srGAP1, srGAP2 and srGAP3 regulate membrane deformation
differently. J Cell Sci. 2012;125(Pt 14):3390–401. doi:10.1242/jcs.098962.
Pérez et al. Neural Development  (2016) 11:11 Page 7 of 8
58. Yao Q, Jin WL, Wang Y, Ju G. Regulated shuttling of Slit-Robo-GTPase
activating proteins between nucleus and cytoplasm during brain
development. Cell Mol Neurobiol. 2008;28(2):205–21. doi:10.1007/
s10571-007-9187-4.
59. Charrier C, Joshi K, Coutinho-Budd J, Kim JE, Lambert N, de Marchena J,
et al. Inhibition of SRGAP2 function by its human-specific paralogs
induces neoteny during spine maturation. Cell. 2012;149(4):923–35.
doi:10.1016/j.cell.2012.03.034.
60. Li X, Chen Y, Liu Y, Gao J, Gao F, Bartlam M, et al. Structural basis of
Robo proline-rich motif recognition by the srGAP1 Src homology 3
domain in the Slit-Robo signaling pathway. J Biol Chem. 2006;281(38):
28430–7. doi:10.1074/jbc.M604135200.
61. Bailey AR, Hou H, Song M, Obregon DF, Portis S, Barger S, et al. GFAP
expression and social deficits in transgenic mice overexpressing human
sAPPalpha. Glia. 2013;61(9):1556–69. doi:10.1002/glia.22544.
62. Li HL, Roch JM, Sundsmo M, Otero D, Sisodia S, Thomas R, et al.
Defective neurite extension is caused by a mutation in amyloid beta/A4
(A beta) protein precursor found in familial Alzheimer’s disease.
J Neurobiol. 1997;32(5):469–80.
63. Reinhard C, Borgers M, David G, De Strooper B. Soluble amyloid-β
precursor protein binds its cell surface receptor in a cooperative
fashion with glypican and syndecan proteoglycans. J Cell Sci. 2013;
126(21):4856–61. doi:10.1242/jcs.137919.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Pérez et al. Neural Development  (2016) 11:11 Page 8 of 8
